- Tony Aquila - Founder, Chairman and CEO
- Renato Giger - Chief Financial Officer
- Jason Brady - Senior Vice President and General Counsel
Founder, Chairman and CEO
Tony Aquila founded Solera Holdings, Inc. (NYSE: SLH) in January 2005 with a vision to transform the automotive insurance claims industry.
Partnering with GTCR Golder Rauner, a leading private equity firm, Solera purchased the Claims Services Group of Automatic Data Processing, Inc. (NYSE: ADP) for $975 million in April 2006. Under Mr. Aquila's leadership, the Company has greatly increased revenue and expanded its geographic reach. In May 2007, Solera closed its initial public offering (IPO) on the New York Stock Exchange. Six months later, the Company completed a secondary stock offering.
Mr. Aquila has more than 20 years of global experience in the manufacturing, distribution, automotive software and collision repair industries. He also has co-invented and patented several products.
Prior to establishing Solera, Mr. Aquila founded MaxMeyer America Inc. (a subsidiary of MaxMeyer Duco, SPA of Italy), an importer and distributor of European refinishing products. He sold this business in 1997 to Fortune 500 company PPG Industries (NYSE: PPG). After that, he founded and served as CEO of Ensera, which developed software that streamlined the automotive collision claims workflow for insurance carriers. Ensera was sold in 2001 to Mitchell International, which appointed Mr. Aquila as its President and COO.
Chief Financial Officer
For almost two decades Renato Giger has been an employee of Solera and its predecessor companies, including the Claims Services Group (CSG), a division of Automated Data Processing, Inc.
Prior to joining Solera he served CSG as Chief Financial Officer of EMEA, Latin America. After the Company's acquisition of CSG in 2006, he became the EMEA Chief Financial Officer, and was appointed Solera's Global Corporate Controller in 2009.
Mr. Giger graduated with a Master's degree in Science from the University of Berne (Switzerland).
Senior Vice President and General Counsel
Prior to joining the Company in March 2008, Jason Brady provided legal consulting services to technology and entertainment organizations. Before that, he was Vice President, General Counsel and Corporate Secretary of biotechnology firm Xenogen Corporation. Brady represented Xenogen in its business defamation and patent infringement litigation with AntiCancer as well as its $80 million acquisition by Caliper Life Sciences, Inc.
As the Director of Legal Affairs for Abbott Diabetes Care, the diabetes testing device division of Abbott Laboratories, Mr. Brady oversaw domestic legal operations. He also worked as Director of Legal Affairs for TheraSense, Inc., a manufacturer of blood glucose monitoring systems. At TheraSense, Brady represented the company during its $131 million initial public offering and its $1.25 billion acquisition by Abbott Laboratories.
Prior to TheraSense, Brady was the General Counsel for Ensera, Inc., a provider of auto collision claims processing software, and Deputy General Counsel for AllAdvantage, a data management company.
At Ensera, he gained valuable insight into the software and services segment of the claims processing industry. During his tenure there he worked closely with Tony Aquila (Solera's Founder, Chairman and CEO) to build the business as a member of the organization's senior management team.
Mr. Brady started his career as an associate at Wilson Sonsini Goodrich & Rosati, P.C. He received a B.A. in History from the University of California Los Angeles, and his J.D. from Santa Clara University School of Law.